CareLit · DOI-Nachweis · NeuroTransmitter
The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions – a Retrospective Study of 50 Patients
DOI 10.1055/s-0043-124377
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMalat, T.-A.; Glombitza, M.; Dahmen, J.; Hax, P.-M.; Steinhausen, E.
ZeitschriftNeuroTransmitter
Ausgabe02/2018
Jahrgang / SeitenJg. 156 · S. 152 bis 159
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Background Treatment of chronic osteomyelitis (COM) remains challenging and often results in large bone defects. Dead space management and proper defect filling are essential for successful treatment. Bioactive glass S53P4 (BAG-S53P4) is an anorganic bone graft substitute with antibacterial, osteoconductive, osteostimulative and angiogenic properties. The aim of our study was to analyse the outcome of patie…
Zitieren
Zitierempfehlung
Malat, T.-A.; Glombitza, M.; Dahmen, J.; Hax, P.-M.; Steinhausen, E (2018) The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions – a Retrospective Study of 50 Patients. NeuroTransmitter, 156 (02), 152 bis 159. https://doi.org/10.1055/s-0043-124377
Mit CareLit weiterarbeiten